Tesevatinib
Ligand Summary
Target Activities
EGFR
Epidermal growth factor receptor
1 Activities
Items per page:
1 – 1 of 1
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
IC50 | 9.52 | J Med Chem, (2019) 62:9:4772 | ||||
MAPKAPK3
MAP kinase-activated protein kinase 3
1 Activities
Items per page:
1 – 1 of 1
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
Kd | 8.7 | Science, (2017) 358:6367:None | ||||
EPHA7
Ephrin type-A receptor 7
1 Activities
Items per page:
1 – 1 of 1
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
Kd | 7.66 | Science, (2017) 358:6367:None | ||||
BCR
Breakpoint cluster region protein
1 Activities
Items per page:
1 – 1 of 1
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
Kd | 6.95 | Science, (2017) 358:6367:None | ||||
EPHA1
Ephrin type-A receptor 1
1 Activities
Items per page:
1 – 1 of 1
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
Kd | 8.1 | Science, (2017) 358:6367:None | ||||